The European Molecular Biology Laboratory (EMBL) is a premier research institution headquartered in Germany, with major operational regions across France, Italy, Spain, and the United Kingdom. Founded in 1974, EMBL has established itself as a leader in molecular biology, focusing on areas such as genomics, proteomics, and bioinformatics. EMBL offers a range of core services, including advanced training, cutting-edge research facilities, and collaborative projects that drive innovation in life sciences. Its unique approach combines interdisciplinary research with state-of-the-art technology, positioning EMBL at the forefront of scientific discovery. With numerous accolades and a strong reputation in the global scientific community, EMBL continues to contribute significantly to advancements in molecular biology, fostering collaboration and excellence in research across Europe and beyond.
How does European Molecular Biology Laboratory's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
European Molecular Biology Laboratory's score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, the European Molecular Biology Laboratory (EMBL) reported total carbon emissions of approximately 51,713,000 kg CO2e. This figure includes 2,478,000 kg CO2e from Scope 1 emissions, 8,852,000 kg CO2e from Scope 2 emissions, and a significant 40,383,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 11,349,000 kg CO2e. Comparatively, in 2022, EMBL's total emissions were about 56,776,000 kg CO2e, with Scope 1 emissions at 2,986,000 kg CO2e, Scope 2 at 9,838,000 kg CO2e, and Scope 3 at 43,952,000 kg CO2e. This indicates a reduction in total emissions of approximately 5,063,000 kg CO2e from 2022 to 2023. EMBL has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded data from a parent organisation. The laboratory's commitment to sustainability is evident in its emissions reporting, although no formal climate pledges or SBTi targets have been established. Overall, EMBL's emissions data reflects a significant reliance on Scope 3 emissions, which typically encompass indirect emissions from the value chain, highlighting an area for potential future focus in their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 2,986,000 | 0,000,000 |
| Scope 2 | 9,838,000 | 0,000,000 |
| Scope 3 | 43,952,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
European Molecular Biology Laboratory has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
